Novo Nordisk's Insulin Move Is Right Medicine
Shares in highly valued diabetes specialist Novo Nordisk jumped on its decision to resubmit insulin Tresiba to U.S. regulators. That is the latest thing to fall into place for the Danish company.
Dow's Deal Makes for a Cleaner Valuation
Dow’s chlorine spinoff marks an important step in raising margins and possibly the chemical company’s valuation multiple.
Japan's Zero Inflation Is No Worry
Inflation in Japan has fallen to zero, but the economy is still headed in the right direction.
Wall Street Banks Bask in Warmer Trading Clime
Divergent central-bank policies are driving up volatility and volume in bond markets. The result is likely to be a rise in trading revenues at big banks.
Mysterious Gas Clouds China Energy Giants
China’s lack of clarity on natural gas pricing leaves a gray area when analyzing energy giants PetroChina and Sinopec.
SanDisk Problems No Flash in the Pan
Two warnings in two months indicate flash memory maker SanDisk’s problems won’t be solved with a quick fix.
Carnival Has Reason to Celebrate
Ahead of the Tape: Cruise operator Carnival Corp. seems on course for more gains.
The Yuan Strikes Back
China’s currency is on a tear despite a weakening economy. When it comes to the yuan, Beijing still pulls the strings.
Bond Funds' Liquidity Presents Market Concern
Bond markets have been encroaching on banking territory. But it appears that bond funds may be taking from banks not only the credit risk that borrowers default, but also a type of maturity transformation risk, of effectively borrowing short to lend long.
Corporate Bonds Left Behind by ECB QE Rush
The European quantitative easing party is in full swing. But while German government bond yields have been dancing to the ECB’s tune, setting new lows, other markets have yet to catch the celebratory mood. That bears watching.
Buffett, Heinz Say Nuts to Soup
The Kraft Foods deal may hurt the valuation of Campbell Soup, seen as a potential deal partner for Heinz.
GameStop Needs to Level Up
Ahead of the Tape: GameStop has been lucky so far, but it will have to develop a new game plan if it is to weather the trend away from store-bought disks toward downloadable games.
Vivendi Investors Shouldn't Double Down With Bolloré
With an activist investor calling for a special payout to shareholders, the attempt by Vivendi’s chairman to double his voting rights at the company looks alarming.
Merck's Self-Medication Is Welcome
Merck’s bigger buyback program signals an absence of attractive acquisition candidates. That should reassure investors.
Negative Rates Mean Tough Life for German Insurers
Companies that have given long-term income guarantees to policyholders face an increasingly tough task to meet them.
China Bank Blues Just Getting Started
Bad loans at China’s banks are on the rise. There’s little relief in sight.
copyright © 2015 Dow Jones & Company, Inc.